Cited 0 times in
Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김성훈 | - |
dc.contributor.author | 김영태 | - |
dc.date.accessioned | 2021-12-28T16:41:03Z | - |
dc.date.available | 2021-12-28T16:41:03Z | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 2005-0380 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/186750 | - |
dc.description.abstract | Since the human papillomavirus (HPV) vaccine guidelines were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2011, 2016, and 2019, several recent studies on the efficacy and safety of HPV vaccines in middle-aged women and men have been reported. Furthermore, there has been an ongoing debate regarding the efficacy of the HPV vaccine in women with prior HPV infection or who have undergone conization for cervical intraepithelial neoplasia (CIN). We searched and reviewed studies on the efficacy and safety of the HPV vaccine in middle-aged women and men and the efficacy of the HPV vaccine in patients infected with HPV and those who underwent conization for CIN. The KSGO updated their guidelines based on the results of the studies included in this review. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Asian Society of Gynecologic Oncology : Taehan Puin Chongyang Hakhoe | - |
dc.relation.isPartOf | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Cervical Intraepithelial Neoplasia* / prevention & control | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Papillomaviridae | - |
dc.subject.MESH | Papillomavirus Infections* / complications | - |
dc.subject.MESH | Papillomavirus Infections* / prevention & control | - |
dc.subject.MESH | Papillomavirus Vaccines* | - |
dc.subject.MESH | Republic of Korea | - |
dc.subject.MESH | Uterine Cervical Neoplasms* / prevention & control | - |
dc.title | Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Obstetrics and Gynecology (산부인과학교실) | - |
dc.contributor.googleauthor | Hyun-Woong Cho | - |
dc.contributor.googleauthor | Kyung-Jin Min | - |
dc.contributor.googleauthor | Sang-Hoon Kwon | - |
dc.contributor.googleauthor | Kidong Kim | - |
dc.contributor.googleauthor | Sunghoon Kim | - |
dc.contributor.googleauthor | Seok Ju Seong | - |
dc.contributor.googleauthor | Yong Jung Song | - |
dc.contributor.googleauthor | Keun Ho Lee | - |
dc.contributor.googleauthor | Shin-Wha Lee | - |
dc.contributor.googleauthor | Jeong-Won Lee | - |
dc.contributor.googleauthor | Woong Ju | - |
dc.contributor.googleauthor | Young Tae Kim | - |
dc.contributor.googleauthor | Jae Kwan Lee | - |
dc.identifier.doi | 10.3802/jgo.2021.32.e94 | - |
dc.contributor.localId | A00595 | - |
dc.contributor.localId | A00729 | - |
dc.relation.journalcode | J01428 | - |
dc.identifier.eissn | 2005-0399 | - |
dc.identifier.pmid | 34708596 | - |
dc.subject.keyword | Female | - |
dc.subject.keyword | Male | - |
dc.subject.keyword | Middle Aged | - |
dc.subject.keyword | Papillomavirus Vaccines | - |
dc.subject.keyword | Practice Guideline | - |
dc.contributor.alternativeName | Kim, Sung Hoon | - |
dc.contributor.affiliatedAuthor | 김성훈 | - |
dc.contributor.affiliatedAuthor | 김영태 | - |
dc.citation.volume | 32 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | e94 | - |
dc.identifier.bibliographicCitation | JOURNAL OF GYNECOLOGIC ONCOLOGY, Vol.32(6) : e94, 2021-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.